The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Stubendorff, Kajsa ^a   Aarsland, Dag ^b,c   Minthon, Lennart ^a   Londos, Elisabet ^a  

^a LUND UNIVERSITY   (Sweden)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CHOLINESTERASE INHIBITOR; LEVODOPA; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; LEWY BODY; LONGITUDINAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; URINE INCONTINENCE;

AUTONOMIC NERVOUS SYSTEM DISEASES; CONSTIPATION; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LEWY BODY DISEASE; LONGITUDINAL STUDIES; PARKINSON DISEASE; PROSPECTIVE STUDIES; SHY-DRAGER SYNDROME; SUPRANUCLEAR PALSY, PROGRESSIVE; URINARY INCONTINENCE;

EID: 84867025905     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045451     Document Type: Article

References (40)

1. Campbell S, Stephens S, Ballard C, (2001) Dementia with Lewy bodies: clinical features and treatment. Drugs & aging 18: 397-407.
2. McKeith IG, (2000) Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. Neurologic clinics 18: 865-902.
3. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, et al. (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68: 812-819.
4. Marti MJ, Tolosa E, Campdelacreu J, (2003) Clinical overview of the synucleinopathies. Movement disorders: official journal of the Movement Disorder Society 18Suppl 6: S21-27.
5. Magierski R, Kloszewska I, Sobow TM, (2010) The influence of vascular risk factors on the survival rate of patients with dementia with Lewy bodies and Alzheimer disease. Neurol Neurochir Pol 44: 139-147.
6. Hanyu H, Sato T, Hirao K, Kanetaka H, Sakurai H, et al. (2009) Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease. Eur J Neurol 16: 212-217.
7. Williams MM, Xiong C, Morris JC, Galvin JE, (2006) Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology 67: 1935-1941.
8. Steenland K, MacNeil J, Seals R, Levey A, (2010) Factors affecting survival of patients with neurodegenerative disease. Neuroepidemiology 35: 28-35.
9. Jellinger KA, Wenning GK, Seppi K, (2007) Predictors of survival in dementia with lewy bodies and Parkinson dementia. Neurodegener Dis 4: 428-430.
10. Bostrom F, Hansson O, Blennow K, Gerhardsson L, Lundh T, et al. (2009) Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies. Dement Geriatr Cogn Disord 28: 314-319.
11. Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, et al. (2007) Autonomic dysfunction in dementia. Journal of neurology, neurosurgery, and psychiatry 78: 671-677.
12. Tada M, Onodera O, Ozawa T, Piao YS, Kakita A, et al. (2007) Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy. Archives of neurology 64: 256-260.
13. Gray WK, Wood BH, Walker RW, (2009) Do autonomic function tests in people with Parkinson's disease predict survival rates at 7 years follow-up? Movement disorders: official journal of the Movement Disorder Society 24: 2432-2434.
14. Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, et al. (2009) Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet neurology 8: 613-618.
15. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, et al. (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65: 1863-1872.
16. El Assaad MA TJ, Asmar RG, (2003) Evaluation of two devices for self-measurements of blood pressure according to the international protocol: The Omron M5-I and the Omron 705IT. Blood pressure monitoring 8: 128-133.
17. Gelinas I, Gauthier L, McIntyre M, Gauthier S, (1999) Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. The American journal of occupational therapy: official publication of the American Occupational Therapy Association 53: 471-481.
18. Committee. GPsdSS (2002) Factors impacting on quality of life in Parkinson's disease: results from an international survey. Movement disorders: official journal of the Movement Disorder Society 17: 60-67.
19. Schrag A, Jahanshahi M, Quinn N, (2000) What contributes to quality of life in patients with Parkinson's disease? Journal of neurology, neurosurgery, and psychiatry 69: 308-312.
20. Chaudhuri KR, Healy DG, Schapira AH, (2006) Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet neurology 5: 235-245.
21. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society 26: 399-406.
22. Committee GPsdSS (2002) Factors impacting on quality of life in Parkinson's disease: results from an international survey. Movement disorders: official journal of the Movement Disorder Society 17: 60-67.
23. Bostrom F, Jonsson L, Minthon L, Londos E, (2007) Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer disease and associated disorders 21: 150-154.
24. Arbogast SD, Alshekhlee A, Hussain Z, McNeeley K, Chelimsky TC, (2009) Hypotension unawareness in profound orthostatic hypotension. The American journal of medicine 122: 574-580.
25. Passant U, Warkentin S, Karlson S, Nilsson K, Edvinsson L, et al. (1996) Orthostatic hypotension in organic dementia: relationship between blood pressure, cortical blood flow and symptoms. Clinical autonomic research: official journal of the Clinical Autonomic Research Society 6: 29-36.
26. Suarez GA, Opfer-Gehrking TL, Offord KP, Atkinson EJ, O'Brien PC, et al. (1999) The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology 52: 523-528.
27. Low PA, (1993) Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clinic proceedings Mayo Clinic 68: 748-752.
28. Thaisetthawatkul P, Boeve BF, Benarroch EE, Sandroni P, Ferman TJ, et al. (2004) Autonomic dysfunction in dementia with Lewy bodies. Neurology 62: 1804-1809.
29. Horimoto Y, Matsumoto M, Akatsu H, Ikari H, Kojima K, et al. (2003) Autonomic dysfunctions in dementia with Lewy bodies. Journal of neurology 250: 530-533.
30. Passant U, Warkentin S, Gustafson L, (1997) Orthostatic hypotension and low blood pressure in organic dementia: a study of prevalence and related clinical characteristics. International journal of geriatric psychiatry 12: 395-403.
31. Andersson M, Hansson O, Minthon L, Ballard CG, Londos E, (2008) The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies. International journal of geriatric psychiatry 23: 192-198.
32. Kovari E, Horvath J, Bouras C, (2009) Neuropathology of Lewy body disorders. Brain research bulletin 80: 203-210.
33. Poewe W, (2009) Clinical measures of progression in Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society 24Suppl 2: S671-676.
34. Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, et al. (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Movement disorders: official journal of the Movement Disorder Society 21: 916-923.
35. Wenning GK, Scherfler C, Granata R, Bosch S, Verny M, et al. (1999) Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. Journal of neurology, neurosurgery, and psychiatry 67: 620-623.
36. Ballard C, O'Brien J, Morris CM, Barber R, Swann A, et al. (2001) The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry 16: 499-503.
37. Helmes E, Bowler JV, Merskey H, Munoz DG, Hachinski VC, (2003) Rates of cognitive decline in Alzheimer's disease and dementia with Lewy bodies. Dement Geriatr Cogn Disord 15: 67-71.
38. Lopez OL, Wisniewski S, Hamilton RL, Becker JT, Kaufer DI, et al. (2000) Predictors of progression in patients with AD and Lewy bodies. Neurology 54: 1774-1779.
39. Kenny RA, Kalaria R, Ballard C, (2002) Neurocardiovascular instability in cognitive impairment and dementia. Annals of the New York Academy of Sciences 977: 183-195.
40. Heims HC, Critchley HD, Martin NH, Jager HR, Mathias CJ, et al. (2006) Cognitive functioning in orthostatic hypotension due to pure autonomic failure. Clinical autonomic research: official journal of the Clinical Autonomic Research Society 16: 113-120.